Avacta Group Plc AVCT

LON: AVCT | ISIN: GB00BYYW9G87 30/04/2025

33,25 GBX (-2,21%)

(-2,21%) 30/04/2025

Grafiek Avacta Group Plc

Grafiek Avacta Group Plc

1 dag1d -2,21%
1 week1w 7,26%
1 maand1m -0,75%
3 maanden3m -30,00%
6 maanden6m -38,43%
1 jaar1j -28,88%
5 jaar5j -69,50%

Avacta Group Plc in het nieuws

Toon enkel gratis nieuws

15 oktober 2024 · Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer · Persbericht

10 oktober 2024 · Avacta to Unveil Pipeline Expansion and Novel, Next-Generational Targeted Cancer Therapy Programs at 2024 EORTC-NCI-AACR Symposium · Persbericht

14 september 2024 · Avacta Reports Updated Phase 1 Clinical Data of AVA6000 at the European Society for Medical Oncology (ESMO) Congress Demonstrating Multiple Ongoing, Durable Responses in Solid Tumors · Persbericht

9 september 2024 · Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress · Persbericht

5 april 2024 · Avacta Group - AVA6000 Abstract Release by AACR and Full Presentation Update · Persbericht

23 oktober 2023 · Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board · Persbericht

Profiel Avacta Group Plc

Commerciële diensten

Diverse commerciële diensten

Gezondheidstechnologie

Productie van medische instrumenten

CEO: Alastair Smith

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe